Together for Short Lives
Call the Helpline 0808 8088 100

Adverse effects of antiepileptic drugs in North Indian pediatric outpatients

Journal title
Clinical neuropharmacology
Publication year
2013
Author(s)
Bansal, D.; Azad, C.; Kaur, M.; Rudroju, N.; Vepa, P.; Guglani, V.
Pages
107-13
Volume
36
Number
4

PURPOSE: The present study investigates the pattern and predictors of treatment-emergent adverse drug reactions (ADRs) in children diagnosed with epilepsy. METHODS: We conducted prospective observational study in a tertiary care teaching hospital on 277 epileptic children. Antiepileptic drug (AED)-associated ADRs, demographic and clinical characteristics, AED regimen, and so on were recorded. Causality, severity, and preventability were performed by World Health Organization-Uppsala Monitoring Center scale, Hartwig’s severity scale, and Schumock and Thornton questionnaire, respectively. RESULTS: Of the enrolled population, 53% children had symptomatic epilepsy, and 51% were in 5- to 10-year age group. More than two-thirds of children were on monotherapy, with phenytoin (n = 176, 63.5%) being the most common AED. Three hundred fifty-three AED-related ADRs were recorded in 175 children (63.2%). Poor scholastic performance (19%) was the most common ADR, followed by gum hypertrophy (13.3%), headache (10.2%), behavioral problems (5.7%), drowsiness (5.7%), and others. Two hundred sixteen ADRs were probable, and 126 ADRs were possible. Severe ADRs were noted in 6 children. Girls (odds ratio [OR], 1.93; 95% confidence interval [95% CI], 1.07-3.45; P = 0.03), children with secondary epilepsy (OR, 3.31; 95% CI, 1.76-6.23; P 5 years) were found to be associated with higher probability of ADR development.

Research abstracts